×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海药物研究所 [80]
合肥物质科学研究院 [21]
高能物理研究所 [17]
深圳先进技术研究院 [16]
过程工程研究所 [15]
上海生物化学与细胞... [12]
更多...
内容类型
期刊论文 [308]
学位论文 [7]
会议论文 [6]
发表日期
2022 [8]
2021 [13]
2020 [28]
2019 [28]
2018 [41]
2017 [45]
更多...
学科主题
Oncology [4]
Engineerin... [3]
Cell Biolo... [2]
Chemistry [2]
Pharmacolo... [2]
Research &... [2]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共321条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Proteomics Analysis Revealed Smad3 as a Potential Target of the Synergistic Anti-tumor Activity of Disulfiram and Cisplatin in Ovarian Cancer
期刊论文
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 卷号: 23
作者:
Du, Ruiping
;
Sun, Feilong
;
Li, Kai
;
Qi, Jian
;
Zhong, Wen
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2023/11/10
Disulfiram
cisplatin resistance
ovarian cancer
proteomics analysis
SMAD3
lactate dehydrogenase
Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors
期刊论文
BMC Medicine, 2022, 卷号: 20, 期号: 1
作者:
Zhang,Pei
;
Du,Yang
;
Bai,Hua
;
Wang,Zhijie
;
Duan,Jianchun
收藏
  |  
浏览/下载:123/0
  |  
提交时间:2022/11/21
Tucidinostat
Tumor microenvironment
PD-L1
CCL5
Solid tumor
9.4 T static magnetic field ameliorates imatinib mesylate-induced toxicity and depression in mice
期刊论文
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022
作者:
Tian, Xiaofei
;
Wang, Chentai
;
Yu, Biao
;
Fan, Yixiang
;
Zhang, Lei
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2022/12/22
Static magnetic fields (SMFs)
Imatinib mesylate
Gastrointestinal stromal tumor (GIST)
Drug toxicity
Depression
Ratiometric co-delivery of hydroxychloroquine and calculated low-dose paclitaxel efficiently suppresses tumor growth in hepatocellular carcinoma mouse models in vivo
期刊论文
NANO TODAY, 2022, 卷号: 44
作者:
Wang, Wenbin
;
Sun, Hui
;
Gong, Yan
;
Liu, Xiangsheng
;
Liu, Xiao
收藏
  |  
浏览/下载:116/0
  |  
提交时间:2022/12/23
Ratiometric co-delivery
Autophagy
Hepatocellular carcinoma
Chemo-immunotherapy
Hydroxychloroquine
Paclitaxel
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers
期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:
Cao, Jiang-yan
;
Qi, Shuang
;
Wu, Hong
;
Wang, Ao-li
;
Liu, Qing-wang
收藏
  |  
浏览/下载:92/0
  |  
提交时间:2022/03/28
HER2
breast cancers
gastric cancers
irreversible inhibitor
drug resistance
Oxygen Self-Supply Engineering-Ferritin for the Relief of Hypoxia in Tumors and the Enhancement of Photodynamic Therapy Efficacy
期刊论文
SMALL, 2022
作者:
Zhu, Yang
;
Jin, Duo
;
Liu, Manman
;
Dai, Yi
;
Li, Li
收藏
  |  
浏览/下载:97/0
  |  
提交时间:2022/03/28
ferritin
manganese dioxide
photodynamic therapy
tumor therapies
Peptidic microarchitecture-trapped tumor vaccine combined with immune checkpoint inhibitor or PI3K gamma inhibitor can enhance immunogenicity and eradicate tumors
期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 卷号: 10, 期号: 2, 页码: 13
作者:
Du, Yang
;
Liu, Ye
;
Wang, Di
;
Bai, Hua
;
Wang, Zhijie
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2022/06/06
immunotherapy
immunogenicity
vaccine
tumor microenvironment
lymphocytes
tumor infiltrating
macrophages
Biomimetic manganese-eumelanin nanocomposites for combined hyperthermia-immunotherapy against prostate cancer
期刊论文
Journal of Nanobiotechnology, 2022, 卷号: 20, 期号: 1
作者:
Liu,Yu
;
Shang,Wenting
;
Liu,Heng
;
Hui,Hui
;
Wu,Jun
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2022/02/16
Tumor-associated macrophages
Immunomodulation
Hyperthermia-immunotherapy
Eumelanin
Prostate cancer
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma
期刊论文
BMC CANCER, 2022, 卷号: 22
作者:
Chen, Xi
;
Kong, Haiying
;
Luo, Linxiang
;
Han, Shuiyun
;
Lei, Tao
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2022/02/14
Hodgkin lymphoma
PD-1 inhibitor
PD-L1 inhibitor
PD-L2
Molecular phenotype
Tumor microenvironment
A Support Vector Machine Based on Liquid Immune Profiling Predicts Major Pathological Response to Chemotherapy Plus Anti-PD-1/PD-L1 as a Neoadjuvant Treatment for Patients With Resectable Non-Small Cell Lung Cancer
期刊论文
FRONTIERS IN IMMUNOLOGY, 2021, 卷号: 12
作者:
Peng, Jie
;
Zou, Dan
;
Han, Lijie
;
Yin, Zuomin
;
Hu, Xiao
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/02/14
non-small cell lung cancer
support vector machine
major pathological response
liquid immune profiling
neoadjuvant treatment
©版权所有 ©2017 CSpace - Powered by
CSpace